Dual Biologic Therapy in Moderate to Severe Pediatric Inflammatory Bowel Disease: A Retrospective Study

por Wlazło, Magdalena, Meglicka, Monika, Wiernicka, Anna, Osiecki, Marcin, Kierkuś, Jarosław
Publicado 2022

Inflammatory bowel disease – one entity with many molecular faces

por Szymańska, Sylwia, Matuszczyk, Malgorzata, Osuch, Magdalena, Meglicka, Monika, Szymanska, Edyta, Bierła, Joanna, Kierkuś, Jaroslaw
Publicado 2019

Oral exclusive enteral nutrition for induction of clinical remission, mucosal healing, and improvement of nutritional status and growth velocity in children with active Crohn’s dis...

por Matuszczyk, Małgorzata, Meglicka, Monika, Landowski, Piotr, Czkwianianc, Elżbieta, Sordyl, Beata, Szymańska, Edyta, Kierkuś, Jarosław
Publicado 2021

The level of faecal calprotectin as a noninvasive biomarker of mucosal healing in children with ulcerative colitis

por Szymańska, Edyta, Meglicka, Monika, Dądalski, Maciej, Osiecki, Marcin, Kotkowicz-Szczur, Marta, Matuszczyk, Małgorzata, Kierkuś, Jarosław
Publicado 2020

Effect of the Crohn’s Disease Exclusion Diet (CDED) on the Fecal Calprotectin Level in Children with Active Crohn’s Disease

por Matuszczyk, Małgorzata, Meglicka, Monika, Wiernicka, Anna, Jarzębicka, Dorota, Osiecki, Marcin, Kotkowicz-Szczur, Marta, Kierkuś, Jarosław
Publicado 2022

Premedication Does Not Influence the Incidence of Infliximab Infusion Reactions in Pediatric Patients with Inflammatory Bowel Disease—A Single Center Case–Control Study

por Szymanska, Edyta, Dadalski, Maciej, Sieczkowska-Golub, Joanna, Jarzebicka, Dorota, Meglicka, Monika, Osiecki, Marcin, Wiernicka, Anna, Lebensztejn, Dariusz M., Korczowski, Bartosz, Kierkus, Jaroslaw
Publicado 2021